Vascepa: payments to doctors
Payments that named Vascepa as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $18M
- Providers
- 67,892
- Transactions
- 429,834
- Average per transaction
- $42
The per-transaction average — $42 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 67,892 providers the average total is $266, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Amarin Pharma Inc. | $17,832,349 | 98.8% |
| Amarin Pharma, Inc. | $203,928 | 1.1% |
| Kowa Pharmaceuticals America, Inc. | $5,117 | 0.0% |